HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gottlieb Looks Like Good Fit At FDA Helm To Supplement Industry

This article was originally published in The Rose Sheet

Executive Summary

Scott Gottlieb’s two stints at FDA and his support for limiting regulation that impedes innovation bode well for a supplement industry anxious for guidance on NDI notifications that aligns more with its expectation for less burdensome requirements than those the agency has stated.


Related Content

US FDA Commissioner Confirmation: Gottlieb To Get Questions On Approval Standards, Ties To Industry
Gottlieb Nomination As US FDA Chief Could Signal Changes To Generic Approval Process





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts